Diagnostic performance of plasma p-tau217 in a memory clinic cohort using the Lumipulse automated platform

Plasma p-tau217 shows excellent results for detecting amyloid pathology at brain level in a clinical setting with an AUC of 0.95. It is a highly specific marker of AD and increases progressively along the disease continuum. Using plasma p-tau217 as an initial diagnostic tool with cut-offs at sensitivities and specificities of 95 or 97.5% could save between 57.4-84.8% of LP/PETs with diagnostic accuracies of 95-97%. Plasma NfL increases progressively at different cognitive stages.

Authors

Institutions

Publication Details

Journal
Alzheimer s Research & Therapy
Published
2025-03-27
DOI
https://doi.org/10.1186/s13195-025-01719-5
Citations
9
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
13.24
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Diagnostic performance of plasma p-tau217 in a memory clinic cohort using the Lumipulse automated platform

Marta Drake-Pérez, Eloy Rodríguez‐Rodríguez, Juan Irure‐Ventura, Maria Teresa Garcı́a-Unzueta et al.
9 citations
Alzheimer s Research & Therapy
Epilepsy research and treatment
13.24
article

Diagnostic performance of plasma p-tau217 in a memory clinic cohort using the Lumipulse automated platform

Marta Drake-Pérez, Eloy Rodríguez‐Rodríguez, Juan Irure‐Ventura, Maria Teresa Garcı́a-Unzueta, Marcos López‐Hoyos, Francisco Martínez‐Dubarbie, María Mercedes Bravo, Sara López‐García, Carmen Lage, Pascual Sánchez‐Juan, Andrea Corrales‐Pardo, María Rivera‐Sánchez, Enrique Marco de Lucas, Marta Fernández‐Matarrubia, Ana Pozueta‐Cantudo, Armando Ruiz, María García‐Martínez, Nancy Heidy Cahuana-Santamaría, Álvaro Nevado-Cáceres, Andrea Valera‐Barrero
article en
9 citations

Abstract

Plasma p-tau217 shows excellent results for detecting amyloid pathology at brain level in a clinical setting with an AUC of 0.95. It is a highly specific marker of AD and increases progressively along the disease continuum. Using plasma p-tau217 as an initial diagnostic tool with cut-offs at sensitivities and specificities of 95 or 97.5% could save between 57.4-84.8% of LP/PETs with diagnostic accuracies of 95-97%. Plasma NfL increases progressively at different cognitive stages.

Alzheimer s Research & TherapyVol. 17(1)
Universidad de Cantabria (ES), Instituto de Salud Carlos III (ES), Biomedical Research Networking Center on Neurodegenerative Diseases (ES), Marqués de Valdecilla University Hospital (ES), Instituto de Investigación Marqués de Valdecilla (ES), Global Brain Health Institute (US)
Openalex Percentile: Top 1%
Epilepsy research and treatment
13.24
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.